2 days ago - The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment access to more patients.

1 day ago - Health regulators have approved the first pill form of the blockbuster drug Wegovy, providing patients with a new option for weight loss and management that eliminates the need for regular injections.

11 hours ago - Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment option for patients with obesity or overweight. Clinical trials, such as OASIS 4, showed the pill's efficacy, with ...

1 day ago - "The FDA approval of Wegovy pill -- the first oral GLP-1 for adults with obesity and overweight with weight-related medical problems -- has the potential to impact millions of Americans," Dave Moore, executive vice president of Novo Nordisk ...

1 day ago - Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Novo Nordisk's (NOVOb.CO), opens new tab weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as ...

1 day ago - A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care

3 hours ago - The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events.

1 day ago - The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs.

1 day ago - ... A 64-week, late-stage study showed participants who took the 25 mg of oral semaglutide once daily lost an average of 16.6% of their body weight, compared with 2.7% for those on a placebo. The injectable version of Wegovy won FDA approval in 2021 ...

The first and only FDA-approved GLP-1 pill to help adults with obesity lose weight and keep it off along with diet and exercise.

1 day ago - U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill....

1 day ago - Novo Nordisk (NVO) “announced that the FDA has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events.

2 days ago - The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

2 days ago - Considering Novo Nordisk is already a leader in the GLP-1 space, today's news that its once-a-day oral Wegovy pill has been approved by the FDA is a significant step in helping the company maintain its leadership position.

1 day ago - (AP Photo/Jacquelyn Martin, File) ... U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

November 11, 2025 - FDA Approved: Yes (First approved June 4, 2021) Brand name: Wegovy Generic name: semaglutide Dosage form: Injection Company: Novo Nordisk Treatment for: Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction, Nonalcoholic Steatohepatitis